1 | ocular diseases and disorders | | | | | | | 2 | 0.82% |
2 | valeda locator search go | | | | | | | 1 | 0.41% |
3 | the use of pbm | | | | | | | 1 | 0.41% |
4 | to treat ocular diseases | | | | | | | 1 | 0.41% |
5 | treat ocular diseases and | | | | | | | 1 | 0.41% |
6 | diseases and disorders the | | | | | | | 1 | 0.41% |
7 | and disorders the science | | | | | | | 1 | 0.41% |
8 | disorders the science learn | | | | | | | 1 | 0.41% |
9 | about the science supporting | | | | | | | 1 | 0.41% |
10 | the science supporting the | | | | | | | 1 | 0.41% |
11 | science supporting the use | | | | | | | 1 | 0.41% |
12 | supporting the use of | | | | | | | 1 | 0.41% |
13 | use of pbm research | | | | | | | 1 | 0.41% |
14 | pbm devices to treat | | | | | | | 1 | 0.41% |
15 | of pbm research learn | | | | | | | 1 | 0.41% |
16 | pbm research learn about | | | | | | | 1 | 0.41% |
17 | research learn about the | | | | | | | 1 | 0.41% |
18 | ongoing clinical studies lets | | | | | | | 1 | 0.41% |
19 | clinical studies lets get | | | | | | | 1 | 0.41% |
20 | studies lets get the | | | | | | | 1 | 0.41% |
21 | lets get the conversation | | | | | | | 1 | 0.41% |
22 | get the conversation started | | | | | | | 1 | 0.41% |
23 | the conversation started contact | | | | | | | 1 | 0.41% |
24 | devices to treat ocular | | | | | | | 1 | 0.41% |
25 | improve vision products developing | | | | | | | 1 | 0.41% |
26 | subscribe home about us | | | | | | | 1 | 0.41% |
27 | caution investigational device limited | | | | | | | 1 | 0.41% |
28 | with amd have the | | | | | | | 1 | 0.41% |
29 | amd have the dry | | | | | | | 1 | 0.41% |
30 | form and 10 have | | | | | | | 1 | 0.41% |
31 | and 10 have the | | | | | | | 1 | 0.41% |
32 | 10 have the wet | | | | | | | 1 | 0.41% |
33 | have the wet form | | | | | | | 1 | 0.41% |
34 | the wet form caution | | | | | | | 1 | 0.41% |
35 | wet form caution investigational | | | | | | | 1 | 0.41% |
36 | form caution investigational device | | | | | | | 1 | 0.41% |
37 | by federal or united | | | | | | | 1 | 0.41% |
38 | preserve improve vision products | | | | | | | 1 | 0.41% |
39 | federal or united states | | | | | | | 1 | 0.41% |
40 | or united states law | | | | | | | 1 | 0.41% |